Maurer brings 25 years of experience in enzymes and biotechnology and was most recently head of Henkel’s biotechnology group.
“Attracting Karl to join us was a very good opportunity to utilize his substantial know-how and network in the industry and is another step towards building the innovative and customer-focused organization we aspire to be.” said Aryan Moelker, CEO of AB Enzymes.
Maurer will also be responsible for leading the company’s entry into other industries.